Publication details
Immunology follow-up after rituximab treatment in pediatric non Hodgkin lymfoma patients
| Title in English | Immunology follow-up after rituximab treatment |
|---|---|
| Authors | |
| Year of publication | 2018 |
| Type | Conference abstract |
| MU Faculty or unit | |
| Citation | |
| Description | Rituximab treatment leads to absolute transitional CD19+ B lymphocytopenia. IgG decrease could be delayed after the B cell recovery in the periphery. Clinical and laboratory sights of antibody secondary deficiency should be regularly monitored. |
| Related projects: |